Do State Decisions to Prioritize Renewals for Medicaid Enrollees Who are Likely Ineligible Affect Early Disenrollment Rates? August 11, 2023 Blog Some states are prioritizing Medicaid renewals for enrollees flagged as likely to be ineligible. Early data from Arizona, Idaho, and Pennsylvania show disenrollment rates for flagged enrollees are higher than for other enrollees. This analysis considers why different state approaches to renewals may explain some – but not all – variation in disenrollment rates across the U.S.
Percent of Private Sector Establishments That Offer Health Insurance to Employees, by Firm Size August 7, 2023 State Indicator
Marketplace Insurers are Proposing a 6% Average Premium Hike for 2024 and Pointing to Inflation as a Key Driver of Costs August 4, 2023 News Release ACA Marketplace insurers are requesting a median premium increase of 6% for 2024, according to a new KFF analysis of the preliminary rate filings. Insurers’ proposed rate changes – most of which fall between 2% and 10% – may change during the review process. Although most Marketplace enrollees receive subsidies…
How Do Dual-Eligible Individuals Get Their Medicare Coverage? July 31, 2023 Issue Brief People who are dually eligible for both Medicare and Medicaid coverage can get their Medicare coverage in a variety of ways. The brief breaks out the data for traditional Medicare, Medicare Advantage plans that are available to all Medicare beneficiaries, and plans that are designed specifically for dual-eligible beneficiaries.
Headed Back To School in 2023: A Look at Children’s Routine Vaccination Trends July 31, 2023 Issue Brief This issue brief examines the most recent trends in children’s routine vaccinations, including COVID-19, and explores what to watch as children head back to school this year.
Health Care Issues in the Early Stages of the 2024 Election July 20, 2023 Perspective In this JAMA Health Forum column, Larry Levitt examines differences in the Republican presidential candidates’ records and positions on health issues, including Medicaid and abortion, that could play a role in the primaries and would set up a sharp contrast in the general election against President Biden.
New Alzheimer’s Drugs Spark Hope for Patients and Cost Concerns for Medicare July 6, 2023 Blog The Food and Drug Administration granted full approval to Leqembi, a new Alzheimer’s drug, on July 6, 2023. This updated policy watch focuses on the implications of Medicare coverage of the drug for program spending as well as equity and affordability issues for beneficiaries, and the potential for the Inflation Reduction Act to address the spending impacts. It also covers additional details from the Centers for Medicare and Medicaid Services about patient registries.
A Closer Look at the Five Largest Publicly Traded Companies Operating Medicaid Managed Care Plans July 6, 2023 Issue Brief This brief takes a closer look at the five largest publicly traded companies operating Medicaid MCOs which account for half of Medicaid MCO enrollment nationally. Information and data reported in this brief come from quarterly company earnings reports, financial filings, and other company materials as well as from national administrative data.
Climate-Related Health Risks Among Workers: Who is at Increased Risk? June 26, 2023 Issue Brief Adults of color, noncitizens, and adults with lower educational attainment and incomes are disproportionately employed in occupations with increased climate-related health risks. Moreover, workers in occupations with increased climate-related health risks are more likely to be uninsured, contributing to challenges accessing health care.
Privately Insured People with Depression and Anxiety Face High Out-of-Pocket Costs June 23, 2023 Issue Brief This analysis finds that privately insured adults who were treated for depression and/or anxiety in 2021 spent almost twice as much on annual out-of-pocket costs compared to enrollees who were not treated for a mental health diagnosis.